Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease

被引:0
|
作者
Hiroshi Naitoh
Hisanori Shoji
Isao Ishikawa
Reina Watanabe
Yuichi Furuta
Shigeru Tomozawa
Hiroaki Igarashi
Sachiko Shinozaki
Hideyuki Katsura
Ryoichi Onozato
Masayoshi Kudoh
机构
[1] Social Insurance Gumma Chuo General Hospital,Gastroenterology and Proctology Center
来源
Journal of Gastrointestinal Surgery | 2005年 / 9卷
关键词
Intraductal papillary mucinous tumor; autosomal dominant polycystic kidney disease; pancreatic cancer;
D O I
暂无
中图分类号
学科分类号
摘要
A 43-year-old male with a history of autosomal dominant polycystic kidney disease (ADPKD) was admitted to our center with severe abdominal pain and was diagnosed with acute pancreatitis. CT showed multiple cysts in the liver and both kidneys along with ADPKD and a cystic mass, 4 cm in diameter, in the pancreatic head. The main pancreatic duct was dilated to 1 cm in diameter. The patient was diagnosed with acute pancreatitis due to intraductal papillary mucinous tumor (IPMT), and pancreatoduodenectomy was performed. Histologic examination revealed a multiloculated cystic tumor filled with mucin in the head of the pancreas. Microscopically, the tumor was diagnosed as adenocarcinoma and was found to have invaded the main pancreatic duct. Although, in addition to our case, only seven cases with association between ADPKD and malignant neoplasms have been reported, five of these cases had neoplasms arising from the pancreas. Therefore, we suggest that some genetic interactions may exist between ADPKD and pancreatic carcinogenesis.
引用
收藏
页码:843 / 845
页数:2
相关论文
共 50 条
  • [41] Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease
    Ecder, Tevfik
    CURRENT HYPERTENSION REVIEWS, 2013, 9 (01) : 2 - 11
  • [42] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2015, 75 : 1797 - 1806
  • [43] Renal disease progression in autosomal dominant polycystic kidney disease
    Higashihara, Eiji
    Horie, Shigeo
    Muto, Satoru
    Mochizuki, Toshio
    Nishio, Saori
    Nutahara, Kikuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (04) : 622 - 628
  • [44] Nephrotic syndrome and autosomal dominant polycystic kidney disease
    Visciano, Bianca
    Di Pietro, Renata A.
    Rossano, Roberta
    Mancini, Antonio
    Zamboli, Pasquale
    Cianciaruso, Bruno
    Pisani, Antonio
    CLINICAL KIDNEY JOURNAL, 2012, 5 (06): : 508 - 511
  • [45] Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease
    Stayner, Cherie
    Brooke, Darby G.
    Bates, Michael
    Eccles, Michael R.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) : 3081 - 3102
  • [46] Drug management of autosomal dominant polycystic kidney disease
    Theivendran, Thiveya
    Ramachandran, Alister
    Rangan, Gopi
    AUSTRALIAN PRESCRIBER, 2022, 45 (05) : 167 - 170
  • [47] Umbilical hernia in autosomal dominant polycystic kidney disease
    Hattori, Yoshinari
    Hoshino, Junichi
    Suwabe, Tatsuya
    Sumida, Keiichi
    Mise, Koki
    Hayami, Noriko
    Sawa, Naoki
    Takaichi, Kenmei
    Ubara, Yoshifumi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 154 - 156
  • [48] Cardiovascular disorders in autosomal dominant polycystic kidney disease
    Hamzaoui, Mouad
    Lamy, Gaspard
    Bellien, Jeremy
    Guerrot, Dominique
    NEPHROLOGIE & THERAPEUTIQUE, 2021, 17 (01): : 18 - 29
  • [49] An update on tolvaptan for autosomal dominant polycystic kidney disease
    Poch, E.
    Rodas, L.
    Blasco, M.
    Molina, A.
    Quintana, L.
    DRUGS OF TODAY, 2018, 54 (09) : 519 - 533
  • [50] Assessment of Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease
    Gigante, Antonietta
    Perrotta, Adolfo Marco
    Tinti, Francesca
    Assanto, Eleonora
    Muscaritoli, Maurizio
    Lai, Silvia
    Cianci, Rosario
    APPLIED SCIENCES-BASEL, 2023, 13 (12):